Pharmacologic profiling of patient-derived xenograft models of primary treatment-na?ve triple-negative breast cancer.
Pharmacologic profiling of patient-derived xenograft models of primary treatment-na?ve triple-negative breast cancer. Sci Rep. 2020 10 21; 10(1):17899.